SCHEMBL20966330

SCHEMBL20966330

CCn1c2ccccc2c2cc(Nc3ccnc(NCCOC)n3)ccc21

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAC1 P63000 1/20 0.67
▸ MAPT P10636 12/20 0.46
▸ HTT P42858 3/20 0.46
▸ POLB P06746 2/20 0.46
▸ TSHR P16473 1/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ CREBBP Q92793 1/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ MKNK1 Q9BUB5 1/20 0.45
▸ MKNK2 Q9HBH9 1/20 0.45
▸ DRD3 P35462 1/20 0.45
▸ KDM4E B2RXH2 9/20 0.44
▸ LMNA P02545 8/20 0.44
▸ HPGD P15428 6/20 0.44
▸ SMN1; SMN2 Q16637 5/20 0.44
▸ ALDH1A1 P00352 3/20 0.44
▸ HCRTR1 O43613 3/20 0.44
▸ RAB9A P51151 2/20 0.44
▸ PAX8 Q06710 1/20 0.44
▸ KDM1A O60341 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20945474 0.89 RAC1 (0.63) RAC1MAPTHTTPOLBTSHR
SCHEMBL20945473 0.88 RAC1 (0.69) RAC1MAPTHTTPOLBTSHR
SCHEMBL20966317 0.82 RAC1 (0.71) RAC1MAPTHTTPOLBTSHR
SCHEMBL29920671 0.82 RAC1 (0.59) RAC1MAPTPOLBTSHRMAPK1
SCHEMBL29920372 0.82 RAC1 (0.71) RAC1MAPTHTTPOLBTSHR
SCHEMBL20966311 0.82 RAC1 (0.59) RAC1MAPTPOLBTSHRMAPK1
SCHEMBL29920699 0.81 RAC1 (0.65) RAC1MAPTHTTPOLBTSHR
SCHEMBL20966319 0.81 RAC1 (0.65) RAC1MAPTHTTPOLBTSHR
SCHEMBL15087053 0.80 RAC1 (1.00) RAC1MAPTHTTPOLBL3MBTL1
SCHEMBL29558403 0.80 RAC1 (1.00) RAC1MAPTHTTPOLBL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11446299-B2 Carbazole EHop-016 derivatives as anticancer and anti-migratory agents UNIVERSITY OF PUERTO RICO (US) 2022-09-20 — — US disclosed
US-11446299-B2 Carbazole EHop-016 derivatives as anticancer and anti-migratory agents UNIVERSITY OF PUERTO RICO (US) 2022-09-20 — — US disclosed
US-20200352941-A1 NOVEL CARBAZOLE EHOP-016 DERIVATIVES AS ANTI-CANCER AND ANTI-MIGRATORY AGENTS UNIV PUERTO RICO (US) 2020-11-12 — — US disclosed
US-10729689-B2 Carbazole EHop-016 derivatives as anti-cancer and anti-migratory agents UNIVERSITY OF PUERTO RICO (US) 2020-08-04 — — US disclosed
US-20190125746-A1 NOVEL CARBAZOLE EHOP-016 DERIVATIVES AS ANTI-CANCER AND ANTI-MIGRATORY AGENTS UNIVERSITY OF PUERTO RICO (PR) 2019-05-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200352941-A1 NOVEL CARBAZOLE EHOP-016 DERIVATIVES AS ANTI-CANCER AND ANTI-MIGRATORY AGENTS CDC42, ARHGEF2, ARHGDIB RAC1 6/4885MAPT 4054/4885HTT 2339/4885
US-11446299-B2 Carbazole EHop-016 derivatives as anticancer and anti-migratory agents CDC42, ARHGEF2, HRAS RAC1 7/4885MAPT 3790/4885HTT 1746/4885
US-20190125746-A1 NOVEL CARBAZOLE EHOP-016 DERIVATIVES AS ANTI-CANCER AND ANTI-MIGRATORY AGENTS CDC42, ARHGEF2, HRAS RAC1 5/4885MAPT 3896/4885HTT 1686/4885
US-10729689-B2 Carbazole EHop-016 derivatives as anti-cancer and anti-migratory agents CDC42, ARHGEF2, GDI2 RAC1 7/4885MAPT 3908/4885HTT 1971/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback